CVEvulnerability

CVE-2020-10627

8.1 HIGH Published 2021-12-01 Modified 2026-06-17 Official page ↗
Status
Modified
Published
2021-12-01
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.1 ([email protected])
7.3 HIGH — CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L
CVSS 3.1 ([email protected])
8.1 HIGH — CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
CVSS 2.0 ([email protected])
4.8 MEDIUM — AV:A/AC:L/Au:N/C:P/I:P/A:N
Weaknesses
CWE-284

Description

Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Affected configurations

• insulet omnipod insulin management system firmware

Related

Weakness · CWE (1)

  • CWE-284 Improper Access Control weakness

References